Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
This study has been completed.
Study NCT00082381 Information provided by Amylin Pharmaceuticals, LLC.
First Received on May 6, 2004. Last Updated on November 5, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Physiological Effects of Drugs
Sponsors listed in this trial
Amylin Pharmaceuticals, LLC.
Eli Lilly and Company
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers